Related Experiment Video
Updated: Oct 25, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Assessing the linear and non-linear association of HbA1c with cardiovascular disease: a Mendelian randomisation study
Shan Luo1, Shiu Lun Au Yeung2, C Mary Schooling1,3
1School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China.
Insights
Genetically predicted HbA1c (glycated hemoglobin) shows a linear, detrimental effect on cardiovascular disease risk, particularly coronary artery disease. This finding highlights the importance of glycemic control for heart health.
Area of Science:
- Cardiovascular disease genetics
- Metabolic health and disease
Background:
- Elevated HbA1c (glycated hemoglobin) is a known risk factor for cardiovascular diseases (CVD).
- The precise nature and shape of the genetic relationship between HbA1c and CVD risk require further elucidation.
Purpose of the Study:
- To investigate the causal effect of genetically predicted HbA1c on the risk of various cardiovascular diseases.
- To determine the shape (linear or non-linear) of the association between genetically predicted HbA1c and CVD risk.
Main Methods:
- Utilized Mendelian randomization (MR) analyses, including univariable, multivariable, and non-linear approaches.
- Employed a large dataset of 373,571 white British participants from the UK Biobank.
- Adjusted for potential confounders such as hemoglobin levels in multivariable MR.
Main Results:
- A 1 mmol/mol increase in genetically predicted HbA1c was associated with increased risk of coronary artery disease (OR 1.03), stroke (OR 1.02), and hypertension (OR 1.02).
- Multivariable MR confirmed the association with coronary artery disease; associations with stroke and hypertension were directionally similar but less precise.
- Non-linear MR analyses indicated a likely linear relationship between genetically predicted HbA1c and cardiovascular outcomes.
Conclusions:
- Genetically predicted HbA1c has a detrimental, linear effect on coronary artery disease risk.
- The observed association is mediated through glycemic characteristics.
- These findings underscore the importance of glycemic control in preventing cardiovascular diseases.
Aims/Hypothesis:
We aimed to evaluate whether genetically predicted HbA1c has an effect on the risk of cardiovascular diseases and investigate the shape of the relationship of genetically predicted HbA1c with cardiovascular diseases.
Methods:
We performed linear univariable, multivariable and non-linear Mendelian randomisation analyses in 373,571 white British participants (mean age 56.9) from the UK Biobank.
Results:
In univariable linear Mendelian randomisation analysis, a 1 mmol/mol increase in genetically predicted HbA1c was associated with higher risk of coronary artery disease (OR 1.03, 95% CI 1.02, 1.05), stroke (OR 1.02, 95% CI 1.00, 1.05) and hypertension (OR 1.02, 95% CI 1.01, 1.03). Multivariable Mendelian randomisation adjusted for the effect of haemoglobin gave a consistent conclusion for coronary artery disease. The associations with stroke and hypertension were directionally similar but with wider CI overlapping the null. Non-linear Mendelian randomisation indicated that the shape of the effect of genetically predicted HbA1c on cardiovascular outcomes was likely linear.
Conclusions/Interpretation:
The study suggests a detrimental effect of HbA1c on coronary artery disease in both men and women, and the effect is via a glycaemic characteristic. The shape of the genetic association of HbA1c with these cardiovascular outcomes, in particular coronary artery disease, is likely to be linear.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Coronary Artery Disease I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Multiple Allele Traits
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

